Sunday, September 18, 2016 6:22:35 PM
Estimated annual cost savings in 2016 for Glatopa 20 mg
versus the daily COPAXONE 20 mg dose is ~$17k per patient
based on US wholesale acquisition costs
http://files.shareholder.com/downloads/MNTA/2590681078x0x907661/F0EBE260-7F36-4535-BAB7-698E8C39F96A/MNTA_Wells_Fargo_Conf_9.9.16.pdf
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM